Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 23, 2024
Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example
Héctor Carlos García-Díaz, Simeon Eremiev, Javier Gómez-Alonso, et al.
Scientific Reports
|
February 22, 2020
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
Mar Riveiro-Barciela, Paula Gubern, Luisa Roade, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
March 28, 2025
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes
Héctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
June 28, 2025
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes
Héctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, et al.
Current Oncology (Toronto, Ont.)
|
September 27, 2023
Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study
Maria-Josep Carreras, Elena Tomás-Guillén, Anna Farriols, et al.
Frontiers in Medicine
|
August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
Frontiers in Medicine
|
September 8, 2022
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
Mònica Sabaté Gallego, Eulàlia Pérez Esquirol, Núria Garcia Doladé, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 10, 2026
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals
Héctor Carlos García-Díaz, Javier Gómez-Alonso, María Teresa Rabuñal-Álvarez, et al.
Pharmaceutics
|
December 31, 2025
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy
Javier Varela-González-Aller, Mario Andrés Sánchez-Salinas, Iñaki Troconiz, et al.
Cancers
|
April 27, 2024
Drug Cost Avoidance Resulting from Participation in Clinical Trials: A 10-Year Retrospective Analysis of Cancer Patients with Solid Tumors
Maria-Josep Carreras, Berta Renedo-Miró, Carolina Valdivia, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 23, 2024
Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example
Héctor Carlos García-Díaz, Simeon Eremiev, Javier Gómez-Alonso, et al.
Scientific Reports
|
February 22, 2020
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
Mar Riveiro-Barciela, Paula Gubern, Luisa Roade, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
March 28, 2025
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes
Héctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
June 28, 2025
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes
Héctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, et al.
Current Oncology (Toronto, Ont.)
|
September 27, 2023
Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study
Maria-Josep Carreras, Elena Tomás-Guillén, Anna Farriols, et al.
Frontiers in Medicine
|
August 1, 2022
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, et al.
Frontiers in Medicine
|
September 8, 2022
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
Mònica Sabaté Gallego, Eulàlia Pérez Esquirol, Núria Garcia Doladé, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 10, 2026
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals
Héctor Carlos García-Díaz, Javier Gómez-Alonso, María Teresa Rabuñal-Álvarez, et al.
Pharmaceutics
|
December 31, 2025
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy
Javier Varela-González-Aller, Mario Andrés Sánchez-Salinas, Iñaki Troconiz, et al.
Cancers
|
April 27, 2024
Drug Cost Avoidance Resulting from Participation in Clinical Trials: A 10-Year Retrospective Analysis of Cancer Patients with Solid Tumors
Maria-Josep Carreras, Berta Renedo-Miró, Carolina Valdivia, et al.
Page
of 2